DXCM Stock Escalating: Is the Pharma Stock Profitable? 

• DXCM surged by 9.99%, and in the last 6 months, the prices of stocks ascended by over 33%. 
• According to WHO 420 million people globally have Diabetes. 

Dexcom, Inc. (NASDAQ: DXCM), founded in 1999 and HQ in San Diego, California, is a healthcare sector giant, especially with their medical devices focused on continuous glucose monitoring (CGM).

At press time, DXCM stock was trading at $117.89 with a jump of 9.99%; the previous close and open were at 107.24. In comparison, its 52-week range was from 66.89 to 134.76. The company’s market cap was strong at 45.54 billion USD, with a volume of 2.55 million shares. 

Including Dexcom, several other medical industry stocks walked on floral paths and mirrored impressive hikes at the time covid-19 came into existence. Although after thoroughly analyzing the graphs of Dexcom, it is noted that the company’s stock was best trading during 2021.  

EDAP TMS(Nasdaq: EDAP) is similar to DXCM; it manufactures medical equipment. At press time, EDAP stock price was trading at $11.10; prices jumped over 1% in an intraday trading session.  

Based on weekly performance, the stock price of DXCM surged by 9.99%, and in the last 6 months, the prices of stocks ascended by over 33%. Medtronic PLC American developing medical equipment in the last trading session, MDT stock price surged over 0.50% in just a few hours. 

The company aims to replace finger stick blood glucose testing and allow remote monitoring systems so that affected people can have a normal life. Increment of glucose percentage in the blood results in Diabetes. 

OXY Q1,Q2 and Q3 Income Statement 

In the first quarter of 2022, DXCM’s total revenue was $628.80, from which net income was $97.30b. The revenue in the second quarter increased by a few percent and was $696.20b, but the net income decreased compared to the first quarter, and the recorded net income was $50.90b.

The third quarter revenue was $769.60b, but the net income was the lowest in all quarters, which was $101.20b.

Diabetes can be understood as when the human pancreas fails to produce insulin or uses the produced insulin appropriately; it results in Diabetes.   

Most people think that Diabetes is not a serious disease and overlook this severe problem. According to reports from WHO, Between 2000 and 2019, there was a 3% increase in age-standardized mortality rates from Diabetes.  

WHO reports note that Diabetes, in the long term, can majorly affect the heart, blood vessels, kidneys, eyes and nerves. Diabetes is one of the most dangerous diseases responsible for kidney failure.  

According to a health survey, more than 420 million people globally have Diabetes, and more than 1.5 million people die because of kidney failure and several other effects caused by Diabetes.  

Disclaimer

The views and opinions stated by the author, or any people named in this article, are for informational purposes only and do not establish financial, investment, or other advice. Investing in or trading crypto assets comes with a risk of financial loss.

Nancy J. Allen is a crypto enthusiast and believes that cryptocurrencies inspire people to be their own banks and step aside from traditional monetary exchange systems. She is also intrigued by blockchain technology and its functioning.

Latest posts by Nancy J. Allen (see all)